Skip to main content
CDC Website

MDR TB

Global tuberculosis report 2023

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.

Global tuberculosis report 2022

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.

Stakeholders Association 2022 Virtual Meeting

Today, TB Alliance held a virtual meeting of its Stakeholders Association and other tuberculosis (TB) and global health stakeholders around the world to highlight the recent rapid communication issued by the World Health Organization (WHO) Global Tuberculosis Programme regarding updated guidelines for treating drug-resistant tuberculosis (DR-TB) and their potential impact on DR-TB therapy.

Tuberculosis: Clinical Policies and Program Manual

This program manual provides information on the NYC Department of Health’s policies, protocols, and recommendations for the prevention, treatment, and control of TB. 

Global tuberculosis report 2020

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.

An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis

This guide details 2020 updates to the WHO guidelines about the global standard of care for drug-resistant TB. The guide also includes messaging and strategies that can be used to advocate for WHO-recommended regimens.

Rapid Communication: Key changes to the treatment of drug-resistant tuberculosis

This document informs national TB programs and stakeholders about the key implications for the treatment of drug-resistant tuberculosis. This resource is available before the release of the updated guidelines in order for planning at the country level. The guidelines are expected to be released in 2020.